References
- Meignan M, Gallamini A, Meignan M, . Report on the First International Workshop on Interim-PET Scan in Lymphoma. Leuk Lymphoma 2009;50:1257–1260.
- Meignan M, Gallamini A, Haioun C, . Report on the Second International Workshop on interim positron emission tomography in lymphoma held in Menton, France, 8 - 9 April 2010. Leuk Lymphoma 2010;51:2171–2180.
- Haioun C, Itti E, Rahmouni A, . [18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: an early prognostic tool for predicting patient outcome. Blood 2005;106:1376–1381.
- Gallamini A, Hutchings M, Rigacci L, . Early interim 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma: a report from a joint Italian-Danish study. J Clin Oncol 2007;25:3746–3752.
- Barrington SF, Qian W, Somer EJ, . Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma. Eur J Nucl Med Mol Imaging 2010;37:1824–1833.
- Lin C, Itti E, Haioun C, . Early 18F-FDG PET for prediction of prognosis in patients with diffuse large B-cell lymphoma: SUV-based assessment versus visual analysis. J Nucl Med 2007;48:1626–1632.
- Lin C, Luciani A, Itti E, . Whole-body diffusion-weighted magnetic resonance imaging with apparent diffusion coefficient mapping for staging patients with diffuse large B-cell lymphoma. Eur Radiol 2011;20:2027–2038.